Physiomics Plc (AIM:PYC)
0.2939
+0.0039 (1.34%)
Dec 5, 2025, 12:40 PM GMT+1
Physiomics Company Description
Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland.
The company offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software.
It also develops technology for use in the field of personalized medicine. The company was incorporated in 2001 and is based in Oxford, the United Kingdom.
Physiomics Plc
| Country | United Kingdom |
| Founded | 2001 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 10 |
| CEO | Peter Sargent |
Contact Details
Address: Milton Park Innovation Centre Oxford, OX14 4RY United Kingdom | |
| Phone | 44 123 5841575 |
| Website | physiomics.co.uk |
Stock Details
| Ticker Symbol | PYC |
| Exchange | London Stock Exchange AIM |
| Fiscal Year | July - June |
| Reporting Currency | GBP |
| ISIN Number | GB00BDR6W943 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Peter Sargent | Chief Executive Officer |
| Anthony Clayden | Chief Financial Officer |
| Peter Sargent | Chief Operating Officer |